|
公司基本資料信息
|
H-1212 | CDR-H3/C2 | C98H120N16O34S2 | 2130.25 | ? | H-Cys-Asp-Leu-Ile-Tyr-Tyr-Asp-Tyr-Glu-Glu-Asp-Tyr-Tyr-Phe-Asp-Cys-OH (Disulfide bond)? |
H-1213 | ? | C73H97N17O18S | 1532.74 | 127134-13-8 | DABCYL-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS Trifluoroacetate salt? |
H-1214 | ? | C46H55N11O7S | 906.08 | 172546-75-7 | H-His-Cys-Lys-Phe-Trp-Trp-OH |
H-1215 | HIV (gp120) Fragment (254-274) | C95H162N28O30S | 2208.57 | 113944-46-0 | H-Cys-Thr-His-Gly-Ile-Arg-Pro-Val-Val-Ser-Thr-Gln-Leu-Leu-Leu-Asn-Gly-Ser-Leu-Ala-Glu-OH |
H-1216 | HIV (gp120) Fragment (308-331) | C114H199N41O31 | 2640.09 | ? | H-Asn-Asn-Thr-Arg-Lys-Ser-Ile-Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys-Ile-Gly-OH |
H-1217 | HIV (gp120) Fragment (318-327) I-10, P18IIIB I10 |
C48H80N16O12 | 1073.26 | ? | H-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-OH |
H-1218 | HIV (gp120) Fragment (421-438) | C99H148N24O25S2 | 2138.54 | 129318-38-3 | H-Lys-Gln-Phe-Ile-Asn-Met-Trp-Gln-Glu-Val-Gly-Lys-Ala-Met-Tyr-Ala-Pro-Pro-OH Trifluoroacetate salt? |
H-1219 | HIV (gp120) Antigenic Peptide | C117H211N41O31S | 2720.29 | 198636-94-1 | H-Cys-Gly-Lys-Ile-Glu-Pro-Leu-Gly-Val-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg-OH Trifluoroacetate salt? |
H-1220 | HIV (gp41) Fragment | C21H38N6O7 | 486.57 | 129426-47-7 | H-Ala-Val-Gly-Ile-Gly-Ala-OH |
H-1221 | HIV (gp41) Antigenic Peptide 5 | C184H282N56O53S2 | 4190.74 | ? | H-Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys-His-Thr-Thr-Val-Pro-Trp-Val-Asn-Asp-Ser-NH2 (Disulfide bond)? |